首页> 外文期刊>Therapeutic Drug Monitoring >Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose
【24h】

Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose

机译:急性肾脏损伤efaviraz / tenofovir Disoproxil umarate / Emtricisabine(Atripla)过量

获取原文
获取原文并翻译 | 示例
           

摘要

We describe a patient with acute renal failure and irreversible kidney damage after an overdose with the fixed dose combination of efavirenz/tenofovir disoproxil fumarate/emtricitabine (Atripla). The acute kidney injury was most probably caused by tenofovir. Efavirenz and emtricitabine seemed relatively safe in overdose. The pharmacokinetics in overdose of all 3 drugs and the effect of hemodialysis on the tenofovir clearance were studied by measuring the plasma concentrations and by the use of clinical pharmacokinetic software.
机译:在过量剂量的情况下,用efaviraz / tenofovir Disoproxil富马特/ Emtrickabine(Atripla)的固定剂量组合过量后,我们描述了患有急性肾功能衰竭和不可逆的肾脏损伤的患者。 急性肾损伤最可能是替诺福韦引起的。 Efaviraz和Emtricitabine似乎在过量服用中相对安全。 通过测量血浆浓度和使用临床药代动力学软件,研究了所有3种药物过量的药代动力学和血液透析对替诺夫血症间隙的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号